These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20508173)

  • 21. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
    Vichinsky EP
    Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
    [No Abstract]   [Full Text] [Related]  

  • 22. Challenges of alloimmunization in patients with haemoglobinopathies.
    Chou ST; Liem RI; Thompson AA
    Br J Haematol; 2012 Nov; 159(4):394-404. PubMed ID: 23034087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
    Allali S; Peyrard T; Amiranoff D; Cohen JF; Chalumeau M; Brousse V; de Montalembert M
    Br J Haematol; 2017 May; 177(4):641-647. PubMed ID: 28402005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
    Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for alloimmunization by patients with sickle cell disease.
    Murao M; Viana MB
    Braz J Med Biol Res; 2005 May; 38(5):675-82. PubMed ID: 15917948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.
    Matteocci A; Pierelli L
    Vox Sang; 2014 Apr; 106(3):197-208. PubMed ID: 24117723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
    Sarkar SK; Shah MS; Begum M; Yunus AM; Aziz MA; Kabir AL; Khan MR; Rahman F; Rahman A
    Mymensingh Med J; 2019 Apr; 28(2):364-369. PubMed ID: 31086152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red cell alloimmunization in sickle cell disease.
    Davies SC; McWilliam AC; Hewitt PE; Devenish A; Brozovic M
    Br J Haematol; 1986 Jun; 63(2):241-5. PubMed ID: 3087406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.
    Boateng LA; Ngoma AM; Bates I; Schonewille H
    Transfus Med Rev; 2019 Jul; 33(3):162-169. PubMed ID: 31345590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
    Roumenina LT; Bartolucci P; Pirenne F
    Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM; Chou ST
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.
    Hendrickson JE; Tormey CA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):635-51. PubMed ID: 27113001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell alloimmunization in sickle cell anemia: more questions than answers?
    Campbell-Lee SA
    Transfusion; 2012 Feb; 52(2):214-6. PubMed ID: 22239207
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.